KBP-2205
N/A
Report date: 2024/02/29 14:02:33
NME
Base Information
Drug NameKBP-2205
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesKaifu (Suzhou) Biological Medicine Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesKaifu (Suzhou) Biological Medicine Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications +[8]
Other Information
ATC CodeN/A
Related LinksN/A